Next-gen weight loss drug retatrutide trial brings it one step closer to FDA approval
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP drugs that aims at three hormone receptors
Lilly weight loss drug results
- A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says Time —
- New Eli Lilly weight loss drug has dramatic effects in clinical trial Washington Examiner —
- Eli Lilly says next-gen obesity drug helps patients lose 28% of body weight - Reuters Reuters —
- New weight-loss shot appears to outperform other obesity drugs on market The Guardian —
- Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express —